Saizen

In the US, Saizen (somatropin systemic) is a member of the drug class growth hormones and is used to treat Adult Human Growth Hormone Deficiency, Pediatric Growth Hormone Deficiency and Short Stature for Age.

US matches:

• Saizen


• Saizen Subcutaneous, Injection

UK matches:

• Saizen 1.33mg (SPC)
• Saizen 3.33mg (SPC)
• Saizen 5.83 mg/ml and 8 mg/ml solution for injection (SPC)
• Saizen 5.83 mg/ml and 8 mg/ml solution for injection (SPC)
• Saizen 8mg click.easy (SPC)

Ingredient matches for Saizen

Somatropine

Somatropine is reported as an ingredient of Saizen in the following countries:

• Australia


• Austria


• Bangladesh


• Brazil


• Bulgaria


• Canada


• China


• Czech Republic


• Estonia


• Finland


• France


• Greece


• Hong Kong


• Hungary


• Iceland


• India


• Ireland


• Italy


• Japan


• Latvia


• Lithuania


• Luxembourg


• New Zealand


• Norway


• Oman


• Peru


• Poland


• Portugal


• Russian Federation


• Singapore


• Spain


• Sri Lanka


• Switzerland


• Taiwan


• Tunisia


• Turkey


• United Kingdom


• United States


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.